Please login to the form below

Not currently logged in
Email:
Password:

venture capital

This page shows the latest venture capital news and features for those working in and with pharma, biotech and healthcare.

UK biotech funding falls 40% between 2018 and 2019

UK biotech funding falls 40% between 2018 and 2019

Out of that amount, £679m was raised in venture capital, £64m was raised in Initial Public Offerings (IPOs) and £596m in all other public financings. ... According to the report, global venture capital deals totalled £14.5bn in 2019, down 12%, with

Latest news

More from news
Approximately 2 fully matching, plus 106 partially matching documents found.

Latest Intelligence

  • AI: the smart money is on the smart thinking AI: the smart money is on the smart thinking

    This is coupled with venture capital (VC) being increasingly attracted to the sector. ... Therefore, it is highly likely that Big Pharma and venture capital will continue to target AI-focused companies in the coming months and years.

  • The search for treatments for Parkinson’s disease The search for treatments for Parkinson’s disease

    is ignited by smaller biotechs, funded by venture capital, start-ups and academia. ... Pfizer itself established a venture capital organisation to fund early-stage projects.

  • Can protein degraders unlock ‘undruggable’ drug targets? Can protein degraders unlock ‘undruggable’ drug targets?

    It raised $30m in its series A in 2017, and followed that up with a second-round fundraising last November that raised $67m and added Pfizer and Sanofi’s venture capital

  • BRIC markets BRIC markets

    The country is attracting increasing amounts of venture capital funding and we are going see some novel medicines developed in those labs being sold in international markets,” he concluded.

  • Driving the innovation engine Driving the innovation engine

    Rapid changes in technology and the increasing availability of venture capital and angel investors now mean that if an employee has a good idea, he or she can rapidly capitalise on ... The boundary is that it’s limited to the stakeholders – including,

More from intelligence
Approximately 0 fully matching, plus 25 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 24 partially matching documents found.

Latest from PMHub

  • Random42 Attending Jefferies 2018 London Healthcare Conference

    This global gathering of leading healthcare executives and institutional, private equity and venture capital investors will address near- and long-term investment opportunities and discuss the mechanisms driving global healthcare.

  • Random42 appoints Bill Collis as Chairman

    He has vast experience in venture capital and private equity funding, intellectual property licensing, mergers and acquisitions and accessing international markets.

  • Managing value: Why early asset development and commercialization is important

    Investors understand that it’s a gamble, but like every gambler they want the best odds. The figures really are staggering: there are companies with assets in development that have capital ... But while venture capital investors are pumping many

  • Big Bear Communications

    We are a Strategic Marketing Consultancy to the pharmaceuticals / biotech sector and our clients include companies from the sector as well as those from the Venture Capital / Private Equity sector.

  • BigBear Communications Ltd

    We are a Strategic Marketing Consultancy to the pharmaceuticals / biotech sector and our clients include companies from the sector as well as those from the Venture Capital / Private Equity sector.

More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics